| Title : Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study - McGill_2013_Diabetes.Care_36_237 |
| Author(s) : McGill JB , Sloan L , Newman J , Patel S , Sauce C , von Eynatten M , Woerle HJ |
| Ref : Diabetes Care , 36 :237 , 2013 |
| Abstract : |
| PubMedSearch : McGill_2013_Diabetes.Care_36_237 |
| PubMedID: 23033241 |
| Title : Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients - Horie_2011_Clin.Ther_33_973 |
| Author(s) : Horie Y , Kanada S , Watada H , Sarashina A , Taniguchi A , Hayashi N , Graefe-Mody EU , Woerle HJ , Dugi KA |
| Ref : Clin Ther , 33 :973 , 2011 |
| Abstract : |
| PubMedSearch : Horie_2011_Clin.Ther_33_973 |
| PubMedID: 21723606 |
| Title : Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects - Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| Author(s) : Graefe-Mody U , Rose P , Ring A , Zander K , Iovino M , Woerle HJ |
| Ref : Drug Metab Pharmacokinet , 26 :123 , 2011 |
| Abstract : |
| PubMedSearch : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| PubMedID: 21084763 |
| Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409 |
| Author(s) : Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA |
| Ref : Diabet Med , 27 :1409 , 2010 |
| Abstract : |
| PubMedSearch : Forst_2010_Diabet.Med_27_1409 |
| PubMedID: 21059094 |
| Title : Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteers - Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| Author(s) : Graefe-Mody EU , Jungnik A , Ring A , Woerle HJ , Dugi KA |
| Ref : Int J Clinical Pharmacology & Therapeutics , 48 :652 , 2010 |
| Abstract : |
| PubMedSearch : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| PubMedID: 20875371 |